ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "innate immunity"

  • Abstract Number: 1015 • 2018 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis Peripheral CD14+ Monocytes Are Hyper-Inflammatory, Hyper-Glycolytic and Retain a Memory Bias Toward M1 Macrophages

    Trudy McGarry1, Megan M. Hanlon2, Clare C. Cunningham3, Douglas J. Veale4 and Ursula Fearon5, 1St. Vincent's University Hospital, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin 4, Ireland, 2Molecular Rheumatology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland, 3Molecular Rheumatology, Molecular Rheumatology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland, 4Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin, Ireland, 5Molecular Rheumatology, School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland

    Background/Purpose: Myeloid cells with a monocyte/macrophages phenotype are present in large numbers in the rheumatoid arthritis (RA) joint, significantly contributing to disease. This study aimed…
  • Abstract Number: 1026 • 2018 ACR/ARHP Annual Meeting

    Autoinflammatory Diseases, Particularly SAVI and Candle, Are Driven By Chronically Active Type I Interferons

    Bernadette Marrero1, Katherine R. Calvo2, Yin Liu3, Angelique Biancotto4, Yan Huang1 and Raphaela Goldbach-Mansky1, 1Translational Autoinflammatory Disease Section (TADS), Laboratory of Clinical Investigation and Microbiology (LCIM), NIAID/NIH, Bethesda, MD, 2Department of Laboratory Medicine, Hematology Section, National Institutes of Health Clinical Center, Bethesda, MD, 3Scientific Review Branch, NIAMS/NIH, Bethesda, MD, 4Center for Human Immunology Autoimmunity and Inflammation (CHI), NIAID, NIH, Bethesda, MD

    Background/Purpose: STING Associated Vasculopathy with onset in Infancy (SAVI)is caused by gain-of-function mutations in TMEM173/STING and Chronic Atypical Neutrophilic Dermatosis with Lipodystrophy and Elevated Temperature…
  • Abstract Number: 1833 • 2018 ACR/ARHP Annual Meeting

    The Vδ2 Subset of Γδt-Cells Are Present at Healthy Human Enthesis and Have Transcriptional and Functional Characteristics Consistent with a Capacity for IL- 17A Production in Response to IL-23

    Richard Cuthbert1, Evangelos M. Fragkakis1, Charlie Bridgewood1, Robert Dunsmuir2, Abdulla Watad3, Abhay Rao2, Almas Khan2, Helena Marzo-Ortega4, Darren Newton5 and Dennis McGonagle1, 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 2Department of Spinal Surgery, National Health Service, Leeds, United Kingdom, 3Department of Internal Medicine 'B', Sheba Medical Center, Ramat Gan, Ramat Gan, Israel, 4NIHR LBRC, LTHT and LIRMM, University of Leeds, Leeds, United Kingdom, 5Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom

    Background/Purpose: Recent mouse studies of SpA pathogenesis have suggested that γδT-cells accumulate at entheseal regions in an IL-23 overexpression model and that these cells are…
  • Abstract Number: 2039 • 2018 ACR/ARHP Annual Meeting

    A Survey of Blood and Synovial Tissue Myeloid Cells in RA Patients By Transcriptional Profiling

    Shurui Bian1, Arthur M. Mandelin II2, Salina Dominguez3, Philip J. Homan4, Gaurav Gadhvi1, Hiam Abdala-Valencia1, Alexander Misharin5, Eric M. Ruderman6, Carla M. Cuda3, Richard M. Pope6, Harris Perlman3 and Deborah R. Winter3, 1Northwestern University Feinberg School of Medicine, Chicago, IL, 2Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Department of Medicine Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 4Division of Rheumatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 5Medicine/pulmonary, Northwestern University Feinberg School of Medicine, Chicago, IL, 6Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Myeloid cells – including dendritic cells (DCs), monocytes, and macrophages – are critical to the pathogenesis of rheumatoid arthritis (RA) through production of pro-inflammatory…
  • Abstract Number: 2091 • 2018 ACR/ARHP Annual Meeting

    Mucosal-Associated Invariant T (MAIT) Cells As a Potential Therapeutic Target for Systemic Lupus Erythematosus

    Goh Murayama1, Asako Chiba2, Atsushi Nomura3, Hirofumi Amano1, Ken Yamaji1, Naoto Tamura1 and Sachiko Miyake4,5, 1Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan, 2Juntendo Univ Sch of Med, Juntendo University School of Medicine, Tokyo, Japan, 3JUNTENDO UNIVERSITY SCHOOL OF MEDICINE, Tokyo, Japan, 4Division of Immunology/NCNP, Natl Institute of Neuroscience, Kodaira Tokyo, Japan, 5Immunology, Juntendo University School of Medicine, Tokyo, Japan

    Background/Purpose: Mucosal-associated invariant T (MAIT) cells are innate T cells that are restricted by the nonpolymorphic MHC-related molecule-1 (MR1) and express a semi-invariant TCRα chain:…
  • Abstract Number: 2854 • 2018 ACR/ARHP Annual Meeting

    Majeed Syndrome Causing LPIN2 mutations May Prevent Bone “Healing” By Rendering M2 Macrophage Proinflammatory

    Farzana Bhuyan1, Adriana Almeida de Jesus1, Rachel VanTries1, Ronit Herzog2, Karen Onel3, Bernadette Marrero1, Yan Huang1, Katherine R. Calvo4, Gina A. Montealegre Sanchez1, Polly Ferguson5 and Raphaela Goldbach-Mansky1, 1Translational Autoinflammatory Disease Section (TADS), Laboratory of Clinical Investigation and Microbiology (LCIM), NIAID/NIH, Bethesda, MD, 2NYU Langone Medical Center, New York, NY, 3Hospital for Special Surgery, New York, NY, 4Department of Laboratory Medicine, Hematology Section, National Institutes of Health Clinical Center, Bethesda, MD, 5Pediatrics, University of Iowa, Iowa City, IA

    Background/Purpose: To study the mechanism that leads to bone inflammation in a 4-year old patient of mixed Puerto Rican and African-American background who presented with…
  • Abstract Number: 33 • 2018 ACR/ARHP Annual Meeting

    Card9 Is a Critical Regulator of Autoimmune Arthritis in SKG Mice

    Ruth Napier1, Ellen Lee1, Emily Vance1, Kimberly Samson2, Paige Snow3, Shimon Sakaguchi4 and Holly Rosenzweig1, 1Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 2Oregon Health & Science University, Portland, OR, 3Molecular Microbiology and Immunology, VA Portland Health Care System, Portland, OR, 4Osaka University, Osaka, Japan

    Background/Purpose: Caspase recruitment domain-containing protein 9 (Card9) is a C-type lectin receptor known for its function in protection against fungal infection and association with human diseases…
  • Abstract Number: 94 • 2018 ACR/ARHP Annual Meeting

    Circulating Soluble MICA Is Associated to Lupus Nephritis and to a TLR/IFN-I Signature in T Cells in a Cohort of Adult SLE Patients

    Maria Perez-Ferro1, Fredeswinda I. Romero-Bueno1, Cristina Serrano del Castillo2, Raquel Largo3, Gabriel Herrero-Beaumont3 and Olga Sanchez-Pernaute4, 1Section for Autoimmune Diseases, Rheumatology, Fundación Jiménez Díaz University Hospital & Health Research Institute, Madrid, Spain, 2Immunology, Fundación Jiménez Díaz University Hospital & Health Research Institute, Madrid, Spain, 3Bone and Joint Research Unit, Fundación Jiménez Díaz University Hospital & Health Research Institute, Madrid, Spain, 4Rheumatology Division. Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

    Background/Purpose: The MHC class I-related chain A (MICA) is a major ligand for the NKG2D receptor of NK and CD8 T cells. MICA expression at…
  • Abstract Number: 97 • 2018 ACR/ARHP Annual Meeting

    Enhanced IFN-α Production By Plasmacytoid Dendritic Cells Is Associated with Increased Toll-like Receptor 7 Retention in the Lysosomes and Exosure to Type I IFN in Systemic Lupus Erythematosus

    Goh Murayama1, Asako Chiba2, Ayako Makiyama2, Ken Yamaji1, Naoto Tamura1 and Sachiko Miyake2, 1Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan, 2Immunology, Juntendo University School of Medicine, Tokyo, Japan

    Background/Purpose: Type I interferon(IFN) appears to contribute to the development of systemic lupus erythematosus (SLE). Overexpression of type I IFN regulated genes has been reported…
  • Abstract Number: 104 • 2018 ACR/ARHP Annual Meeting

    Identification of a Gut Pathobiont Immunostimulatory Lipoglycan Antigen Linked to Lupus Nephritis

    Gregg Silverman1, Nicolas Gisch2, Aidana Omarbekova3 and Doua F. Azzouz4, 1Department of Medicine, New York University School of Medicine, New York, NY, 2Research Center Borstel, Schleswig-Holstein, Germany, 3New York University School of Medicine, New York, NY, 4Medicine, New York University School of Medicine, New York, NY

    Background/Purpose: A transmissible agent has long been suspected in SLE. In a discovery cohort we found that,compared with healthy subjects, Lupus patients had a five-fold…
  • Abstract Number: 1062 • 2017 ACR/ARHP Annual Meeting

    Ptpn22 Regulates Synovial Slam Family Receptor Expression during Toll-like Receptor-Driven Suppression of Inflammatory Arthritis

    David Ewart1, Juan Abrahante Lloréns2 and Erik J. Peterson3, 1Rheumatology, University of Minnesota, Minneapolis, MN, 2Informatics Institute (UMII), University of Minnesota, Minneapolis, MN, 3Center for Immunology/Department of Medicine, University of Minnesota, Minneapolis, MN

    Background/Purpose: Genetic factors contribute strongly to Rheumatoid arthritis (RA) risk. Protein tyrosine phosphatase non-receptor 22 [PTPN22] encodes the hematopoietic-specific Lymphoid Phosphatase [“Lyp”].  A PTPN22 coding…
  • Abstract Number: 1065 • 2017 ACR/ARHP Annual Meeting

    Mucosal-Associated Invariant T Cell Deficiency in Systemic Lupus Erythematosus Is Realted to an Intrinsic Defect in the Ca2+/Calcineurin/NFAT1 Signaling Pathway

    Yong-Wook Park1, Young-Nan Cho2, Hye-Mi Jin1, Tae-Jong Kim3 and Seung-Jung Kee4, 1Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South), 2Rheumatology, Chonnam National University Hospital and Medical School, Gwangju, MN, Korea, Republic of (South), 3Chonnam Nat`l University Medical School&Hospital, Chonnam, Korea, Republic of (South), 4Laboratory Medicine, Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South)

    Background/Purpose: Mucosal-associated invariant T (MAIT) cells contribute to protection against certain microorganism infections and play an important role in mucosal immunity. However, the role of…
  • Abstract Number: 1068 • 2017 ACR/ARHP Annual Meeting

    Impact of TNF Antagonist Treatment on the Gut Microbiome In Vivo

    Odile Gabay1, Jonathan Vicenty2, Grant Wunderlin3, Linda Tiffany2, Wells Wu4, Vahan Simonyan5 and Kathleen A Clouse6, 1Office of Biotechnology Products /Center for Drug Evaluation and Research DBRRI, U.S. Food and Drug Administration, Silver Spring, MD, 2Office of Biotechnology Products, Center for Drug Evaluation and Research, DBRRI, U.S. Food and Drug Administration, Silver Spring, MD, 3Center for Drug Evaluation and Research CDER DBRRI, U.S. Food and Drug Administration, Silver Spring, MD, 4Center for Biologic Evaluation and Research OMPT, U.S. Food and Drug Administration, Silver Spring, MD, 5Center for Biologic Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, 6Office of Biotechnology Products /Center for Drug Evaluation and Research,DBRRI, U.S. Food and Drug Administration, Silver Spring, MD

    Background/Purpose: Auto-immune diseases are in constant progression in the US. Biologic therapeutics have been used successfully to treat these diseases, but have presented some unique…
  • Abstract Number: 1077 • 2017 ACR/ARHP Annual Meeting

    The Lectin Pathway of the Complement System Is Activated in Patients with Systemic Lupus Erythematosus

    Anne Troldborg1,2, Steffen Thiel3, Marten Trendelenburg4, Justa Friebus-Kardash5, Josephine Nehring5, Rudi Steffensen6, Søren Werner Karlskov Hansen7, Magdalena Janina Laska1, Bent Deleuran8, Jens Christian Jensenius1, Anne Voss9 and Kristian Stengaard-Pedersen10, 1Biomedicine, Aarhus University, Aarhus, Denmark, 2clinical medicine, Aarhus University, Aarhus, Denmark, 3Institute of Biomedicine, Aarhus University, Aarhus, DK, Aarhus, Denmark, 4Department of Biomedicine, Division of Internal Medicine, Basel, Switzerland, 5University Hospital Basel, Division of Internal Medicine, Basel, Switzerland, 6Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark, 7Department of Cancer and Inflammation Research, University of Souther Denmark, Odense, Denmark, 8Department of Biomedicine, Aarhus University, Aarhus, Denmark, 9Rheumatology, Odense University Hospital, Odense, Denmark, 10Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark

    Background/Purpose: The pathogenesis of Systemic Lupus Erythematosus (SLE) involves complement activation. It is well established that activation of complement through the classical pathway (CP) and…
  • Abstract Number: 1338 • 2017 ACR/ARHP Annual Meeting

    Important Role of CD11c+ Dendtritic Cells in Inflammatory Arthritis

    Antonia Puchner1, Victoria Saferding1, Michael Bonelli2, Harald Leiss3, Gerhard Krönke4, René Pfeifle5, Josef S. Smolen6, Kurt Redlich7 and Stephan Blüml6, 1Medical University of Vienna, Austria, Vienna, Austria, 2Rheumatology, Medical University of Vienna, Vienna, Austria, 3Rheumatology, Medical University Vienna, Vienna, Austria, 4Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Department of Internal Medicine 3 – Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany., Erlangen, Austria, 5Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 6Medical University Vienna, Division of Rheumatology, Department of Internal Medicine III, Vienna, Austria, 7Division of Rheumatology, Medical University of Vienna, Vienna, Austria

    Background/Purpose: Dendritic cells (DCs) are important antigen presenting cells (APCs) and therefore they play an important role in bridging the innate and the adaptive immune…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 17
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology